Insider Sales Show Tax Strategy, Not Crisis: Esperion Investor Outlook
Looker Benjamin’s recent $2.88 share sale of Esperion is a tax‑related liquidity move, not a bearish signal – focus on clinical milestones for real impact.
3 minutes to read
Esperion Therapeutics Inc